Von Eschenbach Takes Charge
This article was originally published in RPM Report
Executive Summary
The appointment of interim FDA Commissioner Andrew von Eschenbach means that FDA is back to square one in a search for a permanent head of the agency. Von Eschenbach is on a short list of candidates to fill the position permanently. The real story of why Lester Crawford resigned as FDA chief so suddenly indicates Congress was not ready to go to bat for him.